Vertex Pharmaceuticals (VRTX) FCF Margin (2009 - 2026)
Vertex Pharmaceuticals' quarterly FCF Margin came in at 43.35% in Q1 2026, up 1525.0% year-on-year from 2.67% in Q1 2025, and up 296.65% quarter-over-quarter from 10.93% in Q4 2025.
Vertex Pharmaceuticals has reported FCF Margin for 18 years, with the latest figure at 43.35% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1525.0% year-over-year to 43.35%; the trailing twelve-month figure through Mar 2026 stood at 30.37% (up 4163.0% YoY), and the FY2025 full-year result was 26.61%, up 3378.0% from the prior year.
- FCF Margin for Q1 2026 stood at 43.35%, up from 10.93% in the prior quarter.
- The five-year high for FCF Margin was 49.47% in Q2 2022, with the low at 144.49% in Q2 2024.
- Average FCF Margin over 5 years is 25.16%, with a median of 38.61% recorded in 2022.
- Year-over-year, FCF Margin sank 18760 bps in 2024 and jumped 17577 bps in 2025.
- Tracing VRTX's FCF Margin over 5 years: stood at 45.37% in 2022, then plunged by 85 bps to 7.01% in 2023, then surged by 141 bps to 16.9% in 2024, then tumbled by 35 bps to 10.93% in 2025, then soared by 297 bps to 43.35% in 2026.
- The last three FCF Margin figures came in at 43.35% (Q1 2026), 10.93% (Q4 2025), and 37.04% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.35% |
| Dec 31, 2025 | 10.93% |
| Sep 30, 2025 | 37.04% |
| Jun 30, 2025 | 31.28% |
| Mar 31, 2025 | 28.09% |
| Dec 31, 2024 | 16.90% |
| Sep 30, 2024 | 46.97% |
| Jun 30, 2024 | -144.49% |
| Mar 31, 2024 | 46.02% |
| Dec 31, 2023 | 7.01% |
| Sep 30, 2023 | 49.44% |
| Jun 30, 2023 | 43.11% |
| Mar 31, 2023 | 36.12% |
| Dec 31, 2022 | 45.37% |
| Sep 30, 2022 | 38.61% |
| Jun 30, 2022 | 49.47% |
| Mar 31, 2022 | 42.56% |
| Dec 31, 2021 | 45.03% |
| Sep 30, 2021 | 44.09% |
| Jun 30, 2021 | -13.92% |
| Mar 31, 2021 | 49.30% |
| Dec 31, 2020 | 27.27% |
| Sep 30, 2020 | 47.65% |
| Jun 30, 2020 | 66.95% |
| Mar 31, 2020 | 52.55% |
| Dec 31, 2019 | 275.53% |
| Sep 30, 2019 | 32.69% |
| Jun 30, 2019 | 47.53% |
| Mar 31, 2019 | 35.73% |
| Dec 31, 2018 | 34.36% |
| Sep 30, 2018 | 45.94% |
| Jun 30, 2018 | 38.83% |
| Mar 31, 2018 | 34.86% |
| Dec 31, 2017 | 28.32% |
| Sep 30, 2017 | 24.58% |
| Jun 30, 2017 | 30.19% |
| Mar 31, 2017 | 35.62% |
| Dec 31, 2016 | 28.33% |
| Sep 30, 2016 | 12.64% |
| Jun 30, 2016 | 5.86% |
| Mar 31, 2016 | -6.81% |
| Dec 31, 2015 | 4.09% |
| Sep 30, 2015 | -23.43% |
| Jun 30, 2015 | -74.48% |
| Mar 31, 2015 | -177.88% |
| Dec 31, 2014 | -135.91% |
| Sep 30, 2014 | -70.71% |
| Jun 30, 2014 | -114.14% |
| Mar 31, 2014 | -161.49% |
| Dec 31, 2013 | 4.10% |
| Sep 30, 2013 | -14.54% |
| Jun 30, 2013 | -1.07% |
| Mar 31, 2013 | -25.09% |
| Dec 31, 2012 | 3.75% |
| Sep 30, 2012 | 25.17% |
| Jun 30, 2012 | 24.59% |
| Mar 31, 2012 | -0.86% |
| Dec 31, 2011 | 87.75% |
| Sep 30, 2011 | 7.84% |
| Mar 31, 2011 | -259.94% |
| Dec 31, 2010 | -275.52% |
| Sep 30, 2010 | -734.69% |
| Jun 30, 2010 | -374.97% |
| Mar 31, 2010 | -889.79% |
| Dec 31, 2009 | -324.31% |
| Sep 30, 2009 | -105.73% |
| Jun 30, 2009 | -643.36% |
| Mar 31, 2009 | -801.28% |